With the development of molecular diagnostic technology, the blood transfusion industry has gradually recognized and promoted the use of genetic typing methods for identifying red blood cell blood types. It can be used to solve conflicting results in antibody identification or inconsistent results between serology and genotyping, ensuring the safety of blood transfusion for patients to a greater extent.

clinical application

Cellular blood type genotyping and serological methods complement each other, and the application scope of genotyping includes but is not limited to the following:

Solution

In typing, different typing methods and reagents should be selected according to different application scenarios. Weihe Biotechnology provides a systematic, diversified, and full process red blood cell genotyping solution to meet the scientific research and clinical testing needs of customers for over a variety of red blood cell blood types.